News

… and will double again to $100 billion in 2022, says IQVIA

CRM data will be the first data type to be stored; Veeva CRM Suite also gets updated

Meeting and exhibition spans research, regulatory and commercial elements

More IT intelligence can reduce time to therapy for patient support

Questions raised over how prescription dosages translate into bulk consumption; IQVIA ‘stand(s) behind our data methodologies’

HCPC is now accepting entries for its annual award

CEIV Pharma certification is granted for China hub

Total active (powered) fleet is 5,500 units

Evo 1.0 monitoring system combines with Extreme 1.5-L containers and dewars

With new cellular and genetic therapies, the reimbursement process will need to evolve

Connecting with buying influences in integrated delivery networks is a challenge

Pharmaceutical Commerce’s annual market forecast projects 12.7% YOY growth

Purchases totaled $19.3 billion, up 19% over 2016, say Drug Channels' Adam Fein

Move comes as drug pricing policies get heightened attention in Washington

Vantage Consulting Group lends support to the Qu4rtet open-source effort

14th edition attracted 59 commercial plans as respondents, representing 100 million lives

Company celebrates its growth at annual industry event

Specialty-pharma support providers have a potential benefit in behavioral targeting insights

Company offers a risk-mitigation analytics suite to enable pharma monitoring

While nominal spending was up 1.4%, actual net spending was only 0.6% greater than 2016

Projected growth rates for outsourced work range from 12 to 17%

Proprietary processes combine cryogenic and room-temperature steps for adipose tissue

Vaccines for adult disease states and for tropical diseases expand the market beyond traditional pediatric applications

Colorcon will partner with Applied DNA Sciences for pill-coating taggants

Speed to therapy is a benefit

So-called ‘off the shelf’ CAR-T treatments could change the field just as first products enter commercialization

Supply chain security—with DSCSA compliance—could be a near-term use case, says Accenture